Dream Industrial REIT Announces September 2024 Monthly Distribution
Dream Industrial REIT Announces September 2024 Monthly Distribution
DREAM INDUSTRIAL REIT (TSX: DIR.UN) (the “Trust”) announced today its September 2024 monthly distribution in the amount of 5.833 cents per Unit (70 cents annualized). The September distribution will be payable on October 15, 2024 to unitholders of record as at September 30, 2024.
Dream Industrial REIT is an unincorporated, open-ended real estate investment trust. As at June 30, 2024, Dream Industrial REIT owns, manages and operates a portfolio of 339 industrial assets (546 buildings) comprising approximately 71.9 million square feet of gross leasable area in key markets across Canada, Europe, and the U.S. Dream Industrial REIT’s objective is to deliver strong total returns to its unitholders through secure distributions as well as growth in net asset value and cash flow per unit underpinned by its high-quality portfolio and an investment grade balance sheet. For more information, please visit our website at www.dreamindustrialreit.ca.
For further information, please contact:
DREAM INDUSTRIAL REIT
Alexander Sannikov
President and Chief Executive Officer
(416) 365-4106
asannikov@dream.ca
Lenis Quan
Chief Financial Officer
(416) 365-2353
lquan@dream.ca
View source version on businesswire.com: https://www.businesswire.com/news/home/20240918062586/en/
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
Undervalued by 25% and Yielding 5%, This Stock Is a Buy
-
Can AI Predict Future Stock Returns?
-
The Best Energy Stocks to Buy Now
-
10 Undervalued Wide-Moat Stocks
-
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
-
New 4-Star Stocks
-
Intel Fair Value Left Unchanged Despite Qualcomm Takeover Talk